Quarterly report pursuant to Section 13 or 15(d)

Note 10 - Equity - Schedule of Option Activity (Details)

v3.24.3
Note 10 - Equity - Schedule of Option Activity (Details) - USD ($)
$ / shares in Units, $ in Thousands
 9 Months Ended 12 Months Ended
Sep. 30, 2024
Dec. 31, 2023
Outstanding Options (in shares) 134,333  
Outstanding Options, exercise price (in dollars per share) $ 20.77  
Outstanding Options, weighted average contractual term (Year) 3 years 5 months 4 days 6 years 2 months 4 days
Outstanding Options, intrinsic value $ 0 $ 0
Options granted (in shares) 335,728  
Options granted, exercise price (in dollars per share) $ 5.18  
Outstanding Options (in shares) 583,583 134,333
Outstanding Options, exercise price (in dollars per share) $ 23.77 $ 20.77
Non-Vested Options, number (in shares) 90,988  
Non-Vested Options, weighted average grant date fair value (in dollars per share) $ 4.77  
Options granted, weighted average grant date fair value (in dollars per share) $ 4.77  
Options vested, number (in shares) (185,704)  
Options vested, weighted average grant date fair value (in dollars per share) $ 4.94  
Non-Vested Options, number (in shares) 241,012 90,988
Non-Vested Options, weighted average grant date fair value (in dollars per share) $ 4.63 $ 4.77
The Merger [Member]    
Options granted (in shares) 113,522  
Options granted, exercise price (in dollars per share) $ 82.25